Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01433640 · ClinicalTrials.gov registry record
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
A clinical trial, sponsored by Hologic.
- Completed
- Registry status
- 30
- Enrollment target
NCT01433640 is a clinical trial that has completed, run by Hologic. The registered enrollment target is 30 participants.
The verdict
NCT01433640 has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate 2D contrast-enhanced mammography image and 3D (tomosynthesis) contrast-enhanced images to contrast enhanced MRI in women with greater than 95% probability of breast cancer (BIRADS 5) or confirmed breast cancer (BIRADS 6).This study will then be used to design additional studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01433640
The ClinicalTrials.gov registry entry for NCT01433640 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01433640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01433640 about?
NCT01433640 is a clinical study titled "Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study". This is a pilot study to evaluate 2D contrast-enhanced mammography image and 3D (tomosynthesis) contrast-enhanced images to contrast enhanced MRI in women with greater than 95% probability of breast cancer (BIRADS 5) or confirmed breast cancer (BIRADS 6).This study will then be used to design additi...
What is the current status of trial NCT01433640?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-07. Estimated completion is 2014-02.
Who is sponsoring clinical trial NCT01433640?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.